Results 21 to 30 of about 23,893,303 (352)

Emerging Role of Hydrogels in Drug Delivery Systems, Tissue Engineering and Wound Management

open access: yesPharmaceutics, 2021
The popularity of hydrogels as biomaterials lies in their tunable physical properties, ability to encapsulate small molecules and macromolecular drugs, water holding capacity, flexibility, and controllable degradability.
S. Jacob   +5 more
semanticscholar   +1 more source

Compliance with national guidelines for the management of drug-drug interactions in Dutch community pharmacies. [PDF]

open access: yes, 2007
Item does not contain fulltextBACKGROUND: Pharmacists contribute to the detection and prevention of drug therapy-related problems, including drug-drug interactions.
Schalekamp, T.   +6 more
core   +1 more source

Drug management of oxidation-reduction state of the body in respiratory tract diseases (part 3)

open access: yesZdorovʹe Rebenka, 2018
The review of the literature presents modern data on the group of antioxidant drugs — thiol-containing compounds. Their effect on the oxidation-reduction state in diseases of the respiratory system is shown.
A.E. Abaturov   +2 more
doaj   +1 more source

Development of Nanosensors Based Intelligent Packaging Systems: Food Quality and Medicine

open access: yesNanomaterials, 2021
The issue of medication noncompliance has resulted in major risks to public safety and financial loss. The new omnipresent medicine enabled by the Internet of things offers fascinating new possibilities. Additionally, an in-home healthcare station (IHHS),
Ramachandran Chelliah   +9 more
doaj   +1 more source

Mitochondrial adaptation in cancer drug resistance: prevalence, mechanisms, and management

open access: yesJournal of Hematology & Oncology, 2022
Drug resistance represents a major obstacle in cancer management, and the mechanisms underlying stress adaptation of cancer cells in response to therapy-induced hostile environment are largely unknown. As the central organelle for cellular energy supply,
P. Jin   +6 more
semanticscholar   +1 more source

Drug-induced thrombotic microangiopathy: An updated review of causative drugs, pathophysiology, and management

open access: yesFrontiers in Pharmacology, 2023
Drug-induced thrombotic microangiopathy (DITMA) represents 10%–13% of all thrombotic microangiopathy (TMA) cases and about 20%–30% of secondary TMAs, just behind pregnancy-related and infection-related forms.
Tommaso Mazzierli   +3 more
semanticscholar   +1 more source

Recommendations for the Management of Drug–Drug Interactions Between the COVID‐19 Antiviral Nirmatrelvir/Ritonavir (Paxlovid) and Comedications

open access: yesClinical pharmacology and therapy, 2022
The coronavirus disease 2019 (COVID‐19) antiviral nirmatrelvir/ritonavir (Paxlovid) has been granted authorization or approval in several countries for the treatment of patients with mild to moderate COVID‐19 at high risk of progression to severe disease
C. Marzolini   +11 more
semanticscholar   +1 more source

Drug resistant TB - latest developments in epidemiology, diagnostics and management.

open access: yesInternational Journal of Infectious Diseases, 2022
AIM The aim of this review is to inform the reader on the latest developments in epidemiology, diagnostics and management. EPIDEMIOLOGY Drug-resistant Tuberculosis (DR-TB) continues to be a current global health threat, and is defined by higher ...
Simon Tiberi   +7 more
semanticscholar   +1 more source

Clinical risk management in Dutch community pharmacies: the case of drug-drug interactions. [PDF]

open access: yes, 2006
Item does not contain fulltextBACKGROUND: The prevention of drug-drug interactions requires a systematic approach for which the concept of clinical risk management can be used.
Dep Farmaceutische wetenschappen   +5 more
core   +1 more source

Drug management of oxidation-reduction state of the body in respiratory tract diseases (part 5)

open access: yesZdorovʹe Rebenka, 2018
The review of the literature presents modern data on antioxidant activity and immunomodulatory action of vitamin A in diseases of the respiratory system.
A.E. Abaturov   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy